InsiderTrades.com logo

CARM Insider Trading

Insider Ownership Percentage: 6.90%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $138,175.72

Carisma Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Carisma Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Carisma Therapeutics Share Price & Price History

Current Price: $0.05
Price Change: ▼ Price Decrease of -0.0085 (-14.91%)
As of 12/4/2025 04:59 PM ET

This chart shows the closing price history over time for CARM up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Carisma Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/7/2025Michael KlichinskyInsiderSell56,982$0.25$14,245.50View SEC Filing Icon  
10/3/2025Michael KlichinskyInsiderSell119,347$0.26$31,030.22View SEC Filing Icon  
10/2/2025Michael KlichinskyInsiderSell200,000$0.25$50,000.00119,347View SEC Filing Icon  
10/1/2025Michael KlichinskyInsiderSell165,000$0.26$42,900.00319,347View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Carisma Therapeutics (NASDAQ:CARM)

44.27% of Carisma Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CARM by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Carisma Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/14/2025Jane Street Group LLC150,810$59K0.0%N/A0.361%Search for SEC Filing on Google Icon
5/6/2025Universal Beteiligungs und Servicegesellschaft mbH200,000$62K0.0%N/A0.479%Search for SEC Filing on Google Icon
2/17/2025Millennium Management LLC120,157$50K0.0%-15.7%0.288%Search for SEC Filing on Google Icon
2/13/2025Renaissance Technologies LLC231,357$97K0.0%+11.9%0.554%Search for SEC Filing on Google Icon
11/19/2024Barclays PLC549,305$0.54M0.0%+3,661,933.3%1.316%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC259,184$0.25M0.0%-8.5%0.621%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC549,305$0.54M0.0%+3,661,933.3%1.316%Search for SEC Filing on Google Icon
11/15/2024Wexford Capital LP34,861$34K0.0%+75.5%0.083%Search for SEC Filing on Google Icon
9/16/2024Point72 Asia Singapore Pte. Ltd.26,006$40K0.0%N/A0.063%Search for SEC Filing on Google Icon
8/15/2024Point72 Asia Singapore Pte. Ltd.26,006$40K0.0%N/A0.063%Search for SEC Filing on Google Icon
8/15/2024TPG GP A LLC842,031$1.28M0.0%-42.0%2.027%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC139,360$0.21M0.0%-38.3%0.335%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.1,579,961$3.59M0.0%+0.7%3.803%Search for SEC Filing on Google Icon
5/7/2024Empowered Funds LLC26,984$61K0.0%-43.9%0.065%Search for SEC Filing on Google Icon
2/14/2024Trustees of The University of Pennsylvania1,252,107$3.67M10.3%-28.9%3.102%Search for SEC Filing on Google Icon
10/13/2023SG Americas Securities LLC13,653$58K0.0%N/A0.034%Search for SEC Filing on Google Icon
9/21/2023Barclays PLC5,312$47K0.0%N/A0.013%Search for SEC Filing on Google Icon
8/4/2023American International Group Inc.12,834$0.11M0.0%N/A0.032%Search for SEC Filing on Google Icon
7/27/2023EA Series Trust40,434$0.36M0.0%N/A0.100%Search for SEC Filing on Google Icon
6/15/2023Trustees of The University of Pennsylvania2,182,812$6.77M6.6%N/A5.422%Search for SEC Filing on Google Icon
5/15/2023Wittenberg Investment Management Inc.46,703$0.15M0.1%N/A0.459%Search for SEC Filing on Google Icon
5/12/2023Deuterium Capital Management LLC51,256$0.16M0.2%N/A0.504%Search for SEC Filing on Google Icon
5/10/2023Connor Clark & Lunn Investment Management Ltd.14,796$46K0.0%N/A0.145%Search for SEC Filing on Google Icon
5/3/2023Jump Financial LLC17,542$54K0.0%N/A0.172%Search for SEC Filing on Google Icon
5/1/2023Virtu Financial LLC15,335$48K0.0%N/A0.151%Search for SEC Filing on Google Icon
4/27/2023Stratos Wealth Partners LTD.19,899$62K0.0%N/A0.195%Search for SEC Filing on Google Icon
4/24/2023Blodgett Wealth Advisors LLC29,660$92K0.1%N/A0.291%Search for SEC Filing on Google Icon
4/14/2023BML Capital Management LLC411,398$1.28M1.1%N/A4.041%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Carisma Therapeutics logo
Carisma Therapeutics, Inc., a clinical-stage cell therapy company, focuses on discovering and developing immunotherapies to treat cancer and other serious diseases in the United States. The company's ex vivo CAR-M cell therapies include CT-0508, a CAR-macrophage, which is in Phase 1 clinical trial to treat solid tumors; CT-0525, a CAR-monocyte that is in Phase 1 clinical trial to treat solid tumors; and CT-1119, a mesothelin-targeted CAR-Monocyte that is in pre-clinical stage to treat patients with advanced mesothelin-positive solid tumors, including lung cancer, mesothelioma, pancreatic cancer, ovarian cancer, and others. It is also developing in vivo CAR-M cell therapies in collaboration with Moderna Therapeutics to address multiple cancer targets; and multiple assets for the potential treatment of diseases beyond oncology, including fibrosis and other immunologic and inflammatory diseases. The company was formerly known as CARMA Therapeutics Inc. and changed its name to Carisma Therapeutics, Inc. in May 2017. The company was founded in 2016 and is headquartered in Philadelphia, Pennsylvania.
Read More on Carisma Therapeutics

Today's Range

Now: $0.05
Low: $0.04
High: $0.07

50 Day Range

MA: $0.09
Low: $0.03
High: $0.29

52 Week Range

Now: $0.05
Low: $0.03
High: $1.27

Volume

543,528 shs

Average Volume

6,475,001 shs

Market Capitalization

$2.03 million

P/E Ratio

0.07

Dividend Yield

N/A

Beta

1.9

Who are the company insiders with the largest holdings of Carisma Therapeutics?

Carisma Therapeutics' top insider shareholders include:
  1. Michael Klichinsky (Insider)
Learn More about top insider investors at Carisma Therapeutics.